tradingkey.logo

Semler Scientific Inc

SMLR

29.490USD

+1.810+6.54%
Close 09/18, 16:00ETQuotes delayed by 15 min
403.67MMarket Cap
10.90P/E TTM

Semler Scientific Inc

29.490

+1.810+6.54%
More Details of Semler Scientific Inc Company
Semler Scientific, Inc. develops, manufactures, and markets products and services that assist in evaluating and treating chronic diseases. The Company provides technology solutions to healthcare providers. The Company's flagship product, QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient’s vascular condition, including assessments of patients who have vascular disease. QuantaFlo features a sensor clamp that is placed on the toe or finger. Infrared light emitted from the clamp on the dorsal surface of the digit is scattered and reflected by the red blood cells coursing through the area of illumination. Returning light is sensed by the sensor. A blood flow waveform is instantaneously constructed by its proprietary software algorithm. Its customers for QuantaFlo include insurance plans, physician groups, risk assessment groups, hospitals and retailers.
Company Info
Ticker SymbolSMLR
Company nameSemler Scientific Inc
IPO dateFeb 27, 2014
CEODr. Douglas Murphy Chutorian, M.D.
Number of employees79
Security typeOrdinary Share
Fiscal year-endFeb 27
Address51 E Campbell Ave
CityCAMPBELL
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code95008
Phone18777744211
Websitehttps://www.semlerscientific.com/
Ticker SymbolSMLR
IPO dateFeb 27, 2014
CEODr. Douglas Murphy Chutorian, M.D.
Company Executives
Name
Name/Position
Position
Shareholding
Change
Ms. Renae Cormier
Ms. Renae Cormier
Chief Financial Officer
Chief Financial Officer
3.75K
--
Mr. Daniel S. (Dan) Messina, CPA
Mr. Daniel S. (Dan) Messina, CPA
Independent Director
Independent Director
--
--
Mr. Eric Semler, J.D.
Mr. Eric Semler, J.D.
Executive Chairman
Executive Chairman
--
--
Dr. Douglas Murphy Chutorian, M.D.
Dr. Douglas Murphy Chutorian, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. William H.C. Chang
Mr. William H.C. Chang
Independent Director
Independent Director
--
--
Ms. Natalie Brunell
Ms. Natalie Brunell
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Renae Cormier
Ms. Renae Cormier
Chief Financial Officer
Chief Financial Officer
3.75K
--
Mr. Daniel S. (Dan) Messina, CPA
Mr. Daniel S. (Dan) Messina, CPA
Independent Director
Independent Director
--
--
Mr. Eric Semler, J.D.
Mr. Eric Semler, J.D.
Executive Chairman
Executive Chairman
--
--
Dr. Douglas Murphy Chutorian, M.D.
Dr. Douglas Murphy Chutorian, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. William H.C. Chang
Mr. William H.C. Chang
Independent Director
Independent Director
--
--
Ms. Natalie Brunell
Ms. Natalie Brunell
Independent Director
Independent Director
--
--
Revenue Breakdown
FY2025Q1
FY2024
No Data
By RegionUSD
Name
Revenue
Proportion
United States
8.84M
0.00%
By Business
By Region
No Data
Shareholding Stats
Updated: Fri, Sep 5
Updated: Fri, Sep 5
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Interchange Capital Partners LLC
8.68%
Ridgeback Capital Management, L.P.
6.33%
Chang Family Trust
5.98%
Morgan Stanley Investment Management Inc. (US)
5.29%
Semler (Eric J.D.)
4.82%
Other
68.90%
Shareholders
Shareholders
Proportion
Interchange Capital Partners LLC
8.68%
Ridgeback Capital Management, L.P.
6.33%
Chang Family Trust
5.98%
Morgan Stanley Investment Management Inc. (US)
5.29%
Semler (Eric J.D.)
4.82%
Other
68.90%
Shareholder Types
Shareholders
Proportion
Investment Advisor
37.63%
Investment Advisor/Hedge Fund
15.40%
Hedge Fund
11.62%
Corporation
5.98%
Individual Investor
5.98%
Research Firm
4.22%
Bank and Trust
1.89%
Pension Fund
0.28%
Insurance Company
0.02%
Other
16.98%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
298
9.46M
64.54%
-2.91M
2025Q1
306
9.18M
65.25%
-1.97M
2024Q4
283
7.65M
79.85%
-701.13K
2024Q3
251
5.46M
73.24%
-2.13M
2024Q2
249
4.86M
69.19%
-2.60M
2024Q1
242
5.30M
76.14%
-2.30M
2023Q4
246
5.22M
76.05%
-2.80M
2023Q3
234
5.74M
84.95%
-2.76M
2023Q2
217
6.21M
92.58%
-1.36M
2023Q1
188
5.42M
80.78%
-2.08M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Interchange Capital Partners LLC
1.28M
8.74%
+1.28M
--
Mar 31, 2025
Chang Family Trust
884.26K
6.02%
+765.00
+0.09%
Jan 31, 2025
Morgan Stanley Investment Management Inc. (US)
473.10K
3.22%
+148.18K
+45.61%
Mar 31, 2025
Semler (Eric J.D.)
714.12K
4.86%
+6.75K
+0.95%
Jun 11, 2025
Capital International Investors
619.78K
4.22%
+49.17K
+8.62%
Mar 31, 2025
The Vanguard Group, Inc.
440.71K
3%
+134.47K
+43.91%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
466.81K
3.18%
+117.42K
+33.61%
Mar 31, 2025
Driehaus Capital Management, LLC
186.76K
1.27%
-687.00
-0.37%
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI